#cabimer

Disruption Type 1 diabetes mellitus

Current therapies in type I diabetes suppress immune attack or neutralize substances that promote inflammation. This is an innovative strategy that decreases the immune process and promotes the survival and function of beta cells, which produce insulin. Researchers from the Andalusian Center for Molecular Biology and Regenerative Medicine (Cabimer)in Seville and the Biomedical Research Institute…